Shchepin V O, Telnova E A, Proklova T N
The Federal State Budget Scientific Institution "The N. A. Semashko National Research Institute of Public Health", 105064, Moscow, Russia.
The Federal State Budget Scientific Institution "The N. A. Semashko National Research Institute of Public Health", 105064, Moscow, Russia,
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2019 Mar;27(2):108-112. doi: 10.32687/0869-866X-2019-27-2-108-112.
The Federal program of supplementary preferential pharmaceutical support of particular categories of citizen functions since 2005. During this period, it seriously impacted on quality of pharmaceutical support, accessibility of medications, development of pharmaceutical market in general. The article presents analysis of state of pharmaceutical support of particular categories of citizen during 2017-2018. The established problems requiring solution are discussed too. It is established that in majority of cases the problems with pharmaceutical support have organizational specificity. The health care authorities allow decreasing of volumes including shortcomings in purchase and logistic of deliver, untimely holding of auctions, inconsistent compiling of applications and insufficient control of trade stock management. The problems with accessibility of pharmaceuticals occur because of inefficient application of already bought items. The open access data of official web-site of Minzdrav of Russia and Roszdravnadzor were used for analysis and preparation of article.
自2005年起，针对特定类别的公民实施联邦补充优惠药品支持计划。在此期间，该计划对药品支持质量、药品可及性以及整个药品市场的发展都产生了重大影响。本文对2017 - 2018年期间特定类别的公民的药品支持状况进行了分析。同时也讨论了亟待解决的既定问题。经确定，在大多数情况下，药品支持问题具有组织特殊性。医疗保健当局存在诸如采购和配送物流存在缺陷、拍卖举行不及时、申请编制不一致以及对贸易库存管理控制不足等导致药品供应数量减少的情况。药品可及性问题是由于已购药品使用效率低下所致。本文的分析和撰写采用了俄罗斯卫生部和俄罗斯联邦卫生监督局官方网站的公开数据。
